GHU Psychiatrie et Neurosciences
Paris, 75014, France
NCT Number: NCT07340736
In the proposed research, we will assess motor and sensory functions of the hand using clinical tests and a tool designed to measure manual dexterity combined with vibrotactile stimulation. We will also evaluate the integrity of brain structure and function using MRI.
Trial opening soon.
Get Notified18 year–85 year
All sexes
Interventional
Not applicable
Paris, 75014, France
In this study, 90 post-stroke patients will be followed over three visits at 3 weeks, 3 months, and 6 months after stroke. Manual dexterity will be assessed using the Dextrain Manipulandum, both with and without the addition of finger vibrations. These vibrations will be delivered using vibratory rings, a tool that has been developed and is currently being validated in healthy participants and in patients with chronic post-stroke conditions. These measurements will allow us to quantify haptic facilitation, that is the impact of adding finger vibrations on hand motor function.
During each of the three visits, we will also administer validated sensory, motor, and cognitive clinical assessments, as well as anatomical, resting-state functional, and diffusion MRI sequences to investigate brain structure and function in relation to this haptic facilitation. These longitudinal measurements will enable the development of biomarkers of motor recovery of manual dexterity after stroke, with the primary objective of improving the prediction of dexterity recovery using a regression model.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Both patients and healthy participants will perform manual dexterity tasks using the Dextrain Manipulandum. In addition, they will receive finger vibrations delivered via rings that we have previously developed. These vibrations will have a frequency of 150 Hz and will be delivered for a duration of 150 ms.
Subjects and patients will undergo anatomical, resting-state functional, and diffusion brain MRI sequences.
Time frame: 3 months post enrollment
The primary outcome measure is a 10% improvement in the prediction of the Box and Block Test (BBT) score at 3 and 6 months post-stroke achieved by adding the haptic effect to a multivariate model.
Time frame: 3 and 6 months post enrollment
Determine whether the haptic effect calculated during an index finger force control exercise (using the dextrain manipulandum) measured in the acute phase after stroke can improve the prediction of manual dexterity recovery (Box and Blocks Test, BBT) at 3 months and 6 months after stroke.
Time frame: 3 and 6 months post enrollment
Determine whether the haptic effect VS absence of haptic effect improves the prediction of recovery from motor impairment (Fugl Mayer Assessment for Upper Extremity FMA-UE, Purdue Pegboard Test), sensitivity (monofilaments and Nottingham Sensory Assessment), and activity limitations (Stroke Impact Scale) of the upper limb from 3 weeks to 3 and 6 months post-stroke.
Time frame: 3 and 6 months post enrollement
Investigate whether connectivity of fronto-parietal networks at 3 weeks post-stroke predicts recovery of haptic effect and dexterity at 3 and 6 months.
Time frame: 3 and 6 months post stroke
A difference in the change in connectivity between subgroups with versus without haptic effect at 6 months will be investigated.
Time frame: 6 months post enrollement
Compare brain connectivity between the group of healthy subjects and the group of patients at 3 weeks and 6 months post-stroke.
Time frame: 3 and 6 months post stroke
These correlations will be done using Voxel Based Lesion Symptoms Mapping technique (VLSM)
Contact information is provided by the study sponsor or research team.
Centre Hospitalier St Anne
Other
Acronym: HapticS 2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07590349
Brain Diseases, Cardiovascular Diseases
View Trial DetailsNCT06498934
Brain Diseases, Cardiovascular Diseases
Beijing, China
View Trial DetailsNCT06147167
Brain Diseases, Cardiovascular Diseases
Jinan, Shandong, China
View Trial DetailsNCT05701280
Brain Diseases, Cardiovascular Diseases
Phoenix, Arizona, United States
View Trial Details